Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery.

Trial Profile

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2014

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 25 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Jun 2013 Planned End Date changed from 1 Aug 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 14 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top